CXCL-16, IL-17, and bone morphogenetic protein 2 (BMP-2) are associated with overweight and obesity conditions in middle-aged and elderly women.

Ribeiro, Silvana Mara Luz TurbinoLopes, Laís RoqueteCosta, Guilherme de PaulaFigueiredo, Vivian PaulinoBajracharya, Deena ShresthaBatista, Aline PriscilaNicolato, Roney Luiz de CarvalhoOliveira, Fernando Luiz Pereira deEstanislau, Juliana de Assis Silva GomesSilva, André Talvani Pedrosa da2018-01-302018-01-302017RIBEIRO, S. M. L. T. et al. CXCL-16, IL-17, and bone morphogenetic protein 2 (BMP-2) are associated with overweight and obesity conditions in middle-aged and elderly women. Immunity & Ageing, v. 14, p. 1-7, 2017. Disponível em: <https://immunityageing.biomedcentral.com/articles/10.1186/s12979-017-0089-0>. Acesso em: 16 jan. 2018.1742-4933http://www.repositorio.ufop.br/handle/123456789/9387The current concept of overweight/obesity is most likely related to a combination of increased caloric intake and decreased energy expenditure. Widespread inflammation, associated with both conditions, appears to contribute to the development of some obesity-related comorbidities. Interventions that directly or indirectly target individuals at high risk of developing obesity have been largely proposed because of the increasing number of overweight/obese cases worldwide. The aim of the present study was to assess CXCL16, IL-17, and BMP-2 plasma factors in middle-aged and elderly women and relate them to an overweight or obese status. In total, 117 women were selected and grouped as eutrophic, overweight, and obese, according to anthropometric parameters. Analyses of anthropometric and circulating biochemical parameters were followed by plasma immunoassays for CXCL-16, IL- 17, and BMP-2.en-USabertoInflammationElderlyOverweightObesityCXCL-16, IL-17, and bone morphogenetic protein 2 (BMP-2) are associated with overweight and obesity conditions in middle-aged and elderly women.Artigo publicado em periodicoThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. Fonte: o próprio artigo.https://doi.org/10.1186/s12979-017-0089-0